InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Meeter Dalen. Director active across 1 company, notably Singular Genomics Systems, Inc.. In total, 12 disclosures have been published. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Meeter Dalen is linked to Singular Genomics Systems, Inc. (XNAS) as Chief Financial Officer. The declarant has 12 filings in total, and the sampled recent filings cover the period from 2023-06-20 to 2025-02-25, with the most frequent transaction nature shown as option exercise.